FDA's caution in evaluating psychedelics underscores the need for rigorous studies and safety assessments, as more applications are expected for therapeutic uses in the future.
[
Collection
]
[
|
...
]
FDA's caution in evaluating psychedelics underscores the need for rigorous studies and safety assessments, as more applications are expected for therapeutic uses in the future.